Theranostics Conferences and Events

Theranostics combines therapy and diagnostics in a single strategy, platform, or material system, enabling treatment to be guided, monitored, or personalized using diagnostic information. In nanomedicine, theranostics often uses nanoparticles, radiolabeled agents, imaging probes, drug carriers, or responsive materials that can both detect disease features and deliver or activate therapy. The approach is especially relevant to oncology, where diagnosis, targeting, treatment, and response monitoring can be closely linked.

Theranostics matters because it supports more precise medicine by connecting what is seen with what is treated. Nanotheranostic systems can combine imaging contrast, targeted delivery, photothermal therapy, chemotherapy, immunotherapy, or controlled release in one platform. Key challenges include payload balance, safety, clearance, reproducibility, regulatory complexity, and proving clinical benefit. The topic connects closely to cancer nanotechnology, bioimaging, contrast agents, and drug delivery.

Conferences on theranostics appear in nanomedicine, oncology, molecular imaging, nuclear medicine, biotechnology, and pharmaceutical programs. Sessions often cover nanoparticle theranostics, radiotheranostics, image-guided therapy, targeted delivery, and clinical translation. Tracking theranostics events helps researchers follow a field where diagnostics and treatment are increasingly designed as integrated systems.